About Event

OBJECTIVE
Cancer is the second largest disease throughout the world with an increasing mortality rate over the past few years. The patient's survival rate is uncertain due to the limitations of cancer diagnosis and therapy. Early diagnosis of cancer is decisive for its successful treatment. A biomarker-based cancer diagnosis may significantly improve the early diagnosis and subsequent treatment. Biosensors play a crucial role in the detection of biomarkers as they are easy to use, portable, and can do analysis in real time. This seminar describes various biosensors designed for detecting nucleic acid and protein-based cancer biomarkers for cancer diagnosis. It mainly lays emphasis on different approaches to use electrochemical, optical, and mass-based transduction systems in cancer biomarker detection. This seminar highlights the analytical performances of various biosensor designs concerning cancer biomarkers in detail.
The global market for biosensors is expected to reach over $25 billion by 2020. With biosensor applications in such areas as healthcare, environmental, industrial, security and defense, this market is expected to achieve exponential growth over the coming years. This seminar track will focus on the latest in commercialization and technological advances in biosensors.

COURSE CONTENTS
 Introduction to biosensors
 Fabrication strategies for cancer biosensors
 Nucleic acid biomarkers based cancer biosensors
 Electrochemical detection techniques
 Optical detection techniques
 SPR based detection techniques
 Other optical detection techniques
 Protein biomarkers based cancer biosensors
 Fluorescence based detection techniques
 Chemiluminescence based detection techniques
 Mass-based detection techniques
 Piezoelectric biosensors
 Surface acoustic wave (SAW) biosensors
 Microcantilever (MCL)-based biosensors
 Recent Advances in Application of Biosensors in Tissue Engineering
 Current Research Trends, Future Challenges and Limitations of Biosensor Technology